BRIEF-Xeris Biopharma Q4 Net Income USD -5.113 Million

Reuters
06 Mar
BRIEF-Xeris Biopharma Q4 Net Income USD -5.113 Million

Mar 06 (Reuters) - Xeris Biopharma Q4 basic EPS USD -0.03.

  • Q4 operating income USD 1.679 million
  • Q4 product revenue USD 57 million vs. IBES estimate USD 58.1 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10